Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is Buildings and Property in Sweden that focus on global right business. They cover business area such as global right, Nordics, Russia, certain country, Eastern Europe, woman, cancer.
-
Global Right
-
Vallongatan 1
752 28 Uppsala
Sweden
Private
global rightNordicsRussiacertain countryEastern Europewomancancer
* We use standard office opening hours in near Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is Buildings and Property business from Sweden that founded in - ( years old in ), Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) business is focusing on Global Right.
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) headquarter office and corporate office address is located in Vallongatan 1 752 28 Uppsala Sweden.
Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) was founded in Sweden.
In , Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries) is currently focus on global right sector.
Above is snippet of Google Trends for "global right" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oasmia Pharmaceutical (Global Rights For Apealea, Except In Certain European Countries), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
